BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 3524485)

  • 1. Sensitivity in vivo of Plasmodium falciparum to chloroquine and pyrimethamine/sulfadoxine in a coastal area of Tanzania.
    Hedman P; Rombo L; Björkman A; Brohult J; Kihamia CM; Potter J; Stenbeck J
    Ann Trop Med Parasitol; 1986 Feb; 80(1):7-11. PubMed ID: 3524485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo assessment of the sensitivity of Plasmodium falciparum to sulphadoxine/pyrimethamine combination (Fansidar) in six localities in Tanzania where chloroquine-resistant P. falciparum has been detected.
    Kilimali VA; Mkufya AR
    Trans R Soc Trop Med Hyg; 1985; 79(4):482-3. PubMed ID: 3909553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effectiveness of treatment with chloroquine, fansidar and dabequin of Plasmodium falciparum carriers, residing in a hyperendemic focus of malaria (the city of Bagamoyo, Northeastern Tanzania)].
    Kuznetsov RL; Kilama V; Peĭn D; Kampbell SS; Stori D
    Med Parazitol (Mosk); 1985; (4):15-9. PubMed ID: 3903459
    [No Abstract]   [Full Text] [Related]  

  • 4. Sulfadoxine-pyrimethamine for the treatment of acute malaria in children in Papua New Guinea. I. Plasmodium falciparum.
    Darlow B; Vrbova H; Gibney S; Jolley D; Stace J; Alpers M
    Am J Trop Med Hyg; 1982 Jan; 31(1):1-9. PubMed ID: 7036764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fansidar-resistant Plasmodium falciparum infection from Tanzania.
    Vleugels MP; Wetsteyn JC; Meuwissen JH
    Trop Geogr Med; 1982; 34(3):263-5. PubMed ID: 6758246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amodiaquine and sulfadoxine-pyrimethamine as treatment for chloroquine-resistant Plasmodium falciparum in Rwanda.
    Deloron P; Sexton JD; Bugilimfura L; Sezibera C
    Am J Trop Med Hyg; 1988 Mar; 38(2):244-8. PubMed ID: 3281489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In vivo resistance of Plasmodium falciparum to 4-aminoquinolines and to a sulfadoxine-pyrimethamine combination. II--The Emperatriz study, Maranhâo, 1983-1984].
    Passos AD; Osanai CH; Reyes S
    Rev Soc Bras Med Trop; 1987; 20(2):109-13. PubMed ID: 3333871
    [No Abstract]   [Full Text] [Related]  

  • 8. Clearance of falciparum parasitaemia with a single dose sulfadoxine-pyrimethamine in Vientiane, Laos.
    Tawil NA
    Southeast Asian J Trop Med Public Health; 1978 Sep; 9(3):409-13. PubMed ID: 373131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [In vivo resistance of Plasmodium falciparum to 4-aminoquinolines and to a sulfadoxine-pyrimethamine combination. II. Study of Manaus, Amazonas 1983-1984].
    Reyes S; Osanai CH; Passos AD
    Rev Bras Malariol Doencas Trop; 1986; 38():37-44. PubMed ID: 3077193
    [No Abstract]   [Full Text] [Related]  

  • 10. A case of fansidar-resistant Plasmodium falciparum from Tanzania.
    De Geus A; Meuwissen JH; van Rijn A
    Trop Geogr Med; 1982; 34(3):261-3. PubMed ID: 6758245
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative efficacy of alternative primary therapies for Plasmodium falciparum infections in Malawi.
    Heymann DL; Khoromana CO; Wirima JJ; Campbell CC
    Trans R Soc Trop Med Hyg; 1987; 81(5):722-4. PubMed ID: 3329780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A case of malaria tropicameningoencephalitis (neuromalaria) with chloroquine and pyrimethamine/sulfadoxine resistance].
    Niklewski G; Landscheidt H; Glasner H
    Nervenarzt; 1985 Feb; 56(2):101-5. PubMed ID: 3885058
    [No Abstract]   [Full Text] [Related]  

  • 13. Plasmodium falciparum: susceptibility in vitro and in vivo to chloroquine and sulfadoxine-pyrimethamine in Ghanaian schoolchildren.
    Landgraf B; Kollaritsch H; Wiedermann G; Wernsdorfer WH
    Trans R Soc Trop Med Hyg; 1994; 88(4):440-2. PubMed ID: 7570837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined chloroquine/Fansidar-resistant falciparum malaria appears in East Africa.
    Hess U; Timmermans PM; Jones M
    Am J Trop Med Hyg; 1983 Mar; 32(2):217-20. PubMed ID: 6340538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Uncomplicated malaria attack in an area with high resistance to chloroquine. 3. The use of second-choice oral drug treatment].
    Hengy C; Eberlé F; Gazin P; Kouka-Bemba D; Gelas H; Jambou R
    Bull Soc Pathol Exot; 1990; 83(1):61-5. PubMed ID: 2190706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new in vitro test for pyrimethamine/sulfadoxine susceptibility of Plasmodium falciparum and its correlation with in vivo resistance in Kenya.
    Spencer HC; Watkins WM; Sixsmith DG; Koech DK; Chulay JD
    Bull World Health Organ; 1984; 62(4):615-21. PubMed ID: 6386209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chloroquine resistance in Plasmodium falciparum in KwaZulu, 1983-1988.
    Hansford CF
    S Afr Med J; 1989 Nov; 76(10):546-7. PubMed ID: 2686047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of four therapeutic regimens for falciparum malaria in Mozambique, 1986.
    Schapira A; Schwalbach JF
    Bull World Health Organ; 1988; 66(2):219-26. PubMed ID: 3293827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chloroquine and sulfadoxine/pyrimethamine sensitivity in Burkina Faso. In vivo sensitivity of Plasmodium falciparum to chloroquine and sulfadoxine/pyrimethamine in Burkina Faso.
    Del Nero L; Nebie I; Soudouem G; Pietra V
    Trop Geogr Med; 1994; 46(1):8-10. PubMed ID: 8165742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chloroquine and pyrimethamine/sulfadoxine resistant malaria tropica in a child with diabetes mellitus].
    Kroll MH; Bienzle U; Burger W; Weber B
    Monatsschr Kinderheilkd; 1984 May; 132(5):301-2. PubMed ID: 6379425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.